Skip to main content

Table 1 Patient characteristics for contact or no contact with a MDT-HRFS

From: Primary care referral to multidisciplinary high risk foot services – too few, too late

  Contact (n = 40) No Contact (n = 116) Total (n = 156) p-value
Demographics
 Mean Age (±SD) 63.4 (±11.8) 65.5 (±14.1) 65 (±13.5) 0.40
 Male, n (%) 27 (67.5) 78 (67.2) 105 (67.3)  
 Female, n (%) 13 (32.5) 38 (32.8) 51 (32.7) 0.98
Medical history
 Diabetes Type 1, n (%) 4 (10.0) 8 (6.9) 12 (7.7)  
 Diabetes Type 2, n (%) 36 (90.0) 108 (93.1) 144 (92.3) 0.54
 Duration of Diabetes (±SD) 15.5 (±5.7) 15.8 (±8.5) 15.7 (±7.8) 0.86
 HbA1C (mmol/mol)/IFCC 8.4 (±2.2)/68 8.7 (±2.6)/72 8.6 (±2.5)/70.5 0.44
 Peripheral Neuropathy, n (%) 35 (87.5) 97 (83.6) 132 (84.6) 0.56
 Peripheral Arterial Disease, n (%) 33 (82.5) 95 (81.9) 128 (82.1) 0.93
 Ischemic Heart Disease, n (%) 20 (50) 58 (50) 78 (50) 1.00
 Hypertension, n (%) 36 (90) 98 (84.5) 134 (85.9) 0.39
 CKD stage 5, n (%) 9 (22.5) 19 (16.4) 28 (17.9) 0.21
 eGFR (±SD) 41.3 (±26.5) 47.8 (±28.7) 46.2 (±28.2) 0.001*
 Length of Stay, n (IQR) 8 (7–12) 11 (6–24) 10 (10–19.5) 0.63
LAB
 White Cell Count, n (IQR) 10.75 (8–15) 12.1 (10–15) 11.8 (9–15) 0.24
 Presenting ESR (mmol/L), n (IQR) 57 (34–86) 57 (26–77) 57 (27–77) 0.69
 Presenting CRP (mg/l), n (IQR) 76.35 (23–155) 69.75 (32–172) 73.7 (29–166) 0.99
Infection severity
 IDSA grade Moderate, n (%) 28 (70 %) 77 (66.4 %) 105 (67.3 %) 0.68
 IDSA grade Severe, n (%) 12 (30 %) 39 (33.6 %) 51 (32.7 %) 0.68
Texas classification
 1B, n (%) 1 (2.5) 6 (5.2) 7 (4.5) 0.48
 1D, n (%) 6 (15) 21 (18.1) 27 (17.3) 0.66
 2B, n (%) 3 (7.5) 11 (9.5) 14 (9) 0.71
 2D, n (%) 12 (30) 52 (44.8) 64 (41) 0.10
 3B, n (%) 3 (7.5) 5 (4.3) 8 (5.1) 0.43
 3D, n (%) 15 (37.5) 21 (18.1) 36 (23.1) 0.01*
Surgery type
 Surgical debridement, n (%) 7 (17.5) 28 (24.1) 35 (22.4) 0.39
 PTA, n (%) 6 (15) 34 (29.3) 40 (25.6) 0.08*
 Bypass, n (%) 0 (0) 3 (2.6) 3 (1.9) 0.31
 Amputation, n (%) 23 (57.5) 77 (66.4) 100 (64.1) 0.32
 Forefoot/digital, n (%) 16 (40) 51 (44) 67 (42.9) 0.66
 TMA, n (%) 0 (0) 0 (0) 0 (0)  
 BKA, n (%) 8 (20) 18 (15.5) 26 (16.7) 0.51
 AKA, n (%) 0 (0) 8 (6.9) 8 (5.1) 0.09*
  1. ESR erythrocyte sedimentation rate, CRP c-reactive protein, CKD chronic kidney disease, eGFR estimated glomelular filtration rate, PTA percutaneous transluminal angioplasty
  2. *p-value <0.05